Significance of MMP-2 and TIMP-2 mRNA expressions on glomerular cells in the development of glomerulosclerosis

Chinese Medical Sciences Journal

Volumn 19, Issue 2, 2004, Pages 84-88

  Zhang, Zhi Gang ^a   Liu, Xue Guang ^a   Chen, Guang Ping ^a   Zhang, Xiu Rong ^a   Guo, Mu Yi ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Human lupus nephritis; Matrix metalloproteinase; Mesangial cell; Tissue inhibitor of metalloproteinase

Indexed keywords

COLLAGEN TYPE 4; CYCLINE; GELATINASE A; INTERLEUKIN 1; INTERLEUKIN 1BETA; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MESANGIUM CELL; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; RAT;

ANIMALS; CELLS, CULTURED; COLLAGEN TYPE IV; GLOMERULAR MESANGIUM; HUMANS; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MATRIX METALLOPROTEINASE 2; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UP-REGULATION;

EID: 3142626365     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Buyukbabani N, Droz D. Distribution of the extracellular matrix components in human glomerular lesions. J Pathol 1994;172:199-207.
2. Rupprecht HD, Schockimann HO, Sterxal RB. Cell-matrix interactions in the glomemerular mesangium. Kidney Int 1996;49:1575-82.
3. Ool BS, Cohen DJ, Veis JH. Biology of the mesangial cell in glomerulonephritis-role of cytokines. Proc Soc Exp Biol Med 1996;213: 230-8.
4. Li Z, Ling L, Ronaid Z, et al. Increased expression of 72-kd type-IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 1996;148:121-7.
5. Iredale JP, Goddard S, Murphy G, et al. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci 1995;89:75-82.
6. Mauviel AC, Halein P, Vasiloudes CW, et al. Uncoordinate regulation of collagenase, stromelysin and tissue inhibitor of metalloproteinase genes by prostoglanin E2, selective enhancement of collagenase gene expression in human dermal fibroblasts in culture. J Cell Biochem 1994;54:465-72.
7. Kitamura M, Marayyama N, Mitarai T, et al. Heparin selectively inhibits gene expression of matrix metalloproteinase transin in cultured mesangial cells. Biochem Biophys Res Commun 1994;203: 1333-8.
8. Yang C, Dai L, Liu XG, et al. The effect of TGF-β1/Smads signal pathway on the expression of MMP-2 and TIMP-2 in rat mesangial cell. Chin J Pathol 2003;32:553-7
9. Wang J, Chen X, Shi S, et al. Expression of Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in IgA nephropathy. Chin J Intern Med 2002;41:75-8
10. McMillan JI, Riordan JW, Couser WG, et al. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 1996;15:1094-7.
11. Mitani O, Katoh M, Shigematsu H. Participation of the matrix metalloproteinase inhibitor in Thy-1 nephritis. Pathol Int 2004;54:241-50
12. Nakamura T, Ebihara I, Osada S, et al. Gene expression of metalloproteinases and their inhibitor in renal tissue of New Zealand Black/White F1 mice. Clin Sci 1993;85:295-303.
13. Suzuki D, Yagame M, Kim Y, et al. Renal in situ hybridization studies of extracellular matrix related molecules in type I diabetes. Nephron 2002;92:564-72.
14. Sanders JS, Van Goor H, Hanemaai Jer R, et al. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant 2004,19[Epub ahead of orint]
15. Blaser J, Triebed S, Maasjosthusmamn U, et al. Determination of metalloproteinases, plasminogen activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. Clin Chim Acta 1996;244:17-24